StockGuide AI - assistant pour la recherche de marché

Les dirigeants de CVS Health discutent des innovations dans le secteur de la santé lors de la conférence AHIP 2026

06/11/2026, 12:36 PM business research healthcare

CVS Health utilise la technologie de l'IA pour rationaliser les processus de santé et améliorer l'expérience des patients, ce qui pourrait avoir un impact significatif sur l'efficacité du système de santé et les résultats pour les patients dans les années à venir.

Les analystes s'attendent à un retournement potentiel pour l'ETF iShares U.S. Medical Devices (IHI) au milieu d'indicateurs techniques en amélioration

06/10/2026, 11:36 AM investing forecast Analysts: analysts healthcare

L'ETF iShares U.S. Medical Devices (IHI) montre des signes d'un potentiel retournement après une tendance baissière prolongée, ce qui pourrait offrir un scénario de risque/rendement favorable pour les investisseurs. Des indicateurs techniques récents suggèrent que l'IHI pourrait être prêt pour un rebond alors qu'il teste des niveaux de support clés.

Les traders considèrent Cigna (CI) comme un investissement stable en période de volatilité du marché

06/10/2026, 10:37 AM investing review healthcare

Cigna est mise en avant comme une option d'investissement stable en raison de la volatilité du marché, avec des bénéfices solides et un programme de rachat significatif qui la rend attrayante pour les investisseurs axés sur le revenu.

Jim Cramer Maintains Position in Eli Lilly (LLY) Amid Strong Obesity Drug Pipeline

06/08/2026, 12:35 PM business review healthcare

Eli Lilly's stock continues to rise, driven by promising data on its obesity drug retatrutide, prompting analysts and investors to maintain their positions despite the stock's significant gains.

Zealand Pharma (ZEAL) Shares Plunge 23% Following Safety Concerns Over Survodutide Data

06/08/2026, 12:35 PM business stock_drop healthcare

Zealand Pharma's shares fell sharply by 22.7% following concerns over the safety profile of its weight loss drug survodutide, which showed a high dropout rate due to gastrointestinal side effects in a late-stage study. This decline highlights the challenges the company faces in a competitive market dominated by established players like Novo Nordisk and Eli Lilly.

Analysts expect Johnson & Johnson (JNJ) to show potential for breakout following Eli Lilly’s (LLY) recent all-time highs

06/08/2026, 11:35 AM investing forecast Analysts: analysts pharma healthcare

Pharmaceutical stocks are gaining momentum, with Eli Lilly leading the charge and reaching all-time highs, indicating a potential for broader sector strength that could benefit other major companies like Johnson & Johnson.

Novo Nordisk and Eli Lilly Compete for Dominance in the GLP-1 Pill Market Ahead of Medicare Coverage

06/08/2026, 10:48 AM business review healthcare

Novo Nordisk and Eli Lilly are intensifying their competition in the GLP-1 pill market as they prepare for Medicare coverage, which could significantly increase access to their obesity treatments. Both companies are focusing on marketing strategies to appeal to seniors, who will soon be able to access these medications at a reduced cost.

AstraZeneca CEO Pascal Soriot Highlights AI’s Role in Enhancing Drug Development Efficiency

06/05/2026, 03:33 PM growth healthcare

AstraZeneca's CEO Pascal Soriot highlighted the transformative role of artificial intelligence in accelerating drug development and enhancing decision-making processes, which could significantly improve the company's productivity and success rates in clinical trials.

Analysts Bank of America and Goldman Sachs recommend buying Nvidia (NVDA) and Sotera Health (SHC) respectively, while JPMorgan upgrades Tesla (TSLA) to neutral

06/05/2026, 05:34 AM investing review Analysts: analysts, Bank of America, Goldman Sachs, JPMorgan software healthcare

Recent analyst calls highlight significant shifts in ratings and price targets for various companies, indicating potential investment opportunities and risks for investors. Notably, firms like JPMorgan and Goldman Sachs are optimistic about companies like Qualcomm and Tesla, while others like BTIG and Berenberg express caution on Lululemon and CrowdStrike.

Dow Jones Industrial Average Hits Record High as Health-Care Stocks Lead Market Gains

06/05/2026, 05:34 AM business review healthcare

Despite a decline in chip stocks, the U.S. stock market saw significant gains, with the Dow Jones Industrial Average reaching a new record, driven largely by strong performance in the health-care sector.

Topic: healthcare